Wiebe Olijve

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ.

Coöperatieve Rabobank UA provides corporate, investment banking and financial solutions. It operates through the following segments: Domestic Retail Banking, Wholesale, Rural & Retail (WRR), Leasing, Real Estate and Other Segments. The Domestic Retail Banking segment engages in the activities of the local Rabobanks, Obvion, Financial Solutions and Roparco. The WRR segment engages in the wholesale activities in Netherlands and focuses on the Food & Agri Sectors. The Leasing segment engages in the provision of leasing products. The Real Estate segment consists of the activities of Bouwfonds Property Development. The Other segment comprises the financial results of the investments in associates and Treasury and Head Office operations. The company was founded in 1972 and is headquartered in Utrecht, the Netherlands.

Vereniging Aegon NV operates as holding firm, which engages in the provision of financial services. The company was founded in 1978 and is headquartered in The Hague, the Netherlands.

ORIX Corporation Europe NV operates as a financial holding company with interests in the automotive sector, real estate, the environment and energy sectors. The company is headquartered in Rotterdam, the Netherlands.

PCM Uitgevers BV provides publishing services. It publishes daily newspapers, educational publications including dictionaries, general fiction, fantasy, Dutch language software for children & adults, travel guides and trade books. The firm operates business through its subsidiaries. The company was founded in December 1995 and is headquartered in Amsterdam, the Netherlands.

Waterland Private Equity Investments BV is a Private Equity firm, a subsidiary of Waterland Management Holding IV BV founded in 1999 by Robertus H.L.M. Thielen. Waterland Private Equity Investments BV is headquartered in Bussum with additional offices around the world.

Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom.

Rivean Capital BV (Rivean Capital) is a private equity subsidiary of Rivean Capital Management Holding BV founded in 1982. The firm is headquartered in Amsterdam, the Netherlands.

Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ.

Evolva SA is a Swiss-headquartered, international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform. The company was founded in Switzerland in 2004 based on US/Danish technology. Evolva is headquartered in Allschwil/Basel with operations in Denmark, India and the USA. The Company has raised CHF 38.2 million of equity to date and employs 75 persons of whom 30 are based in Allschwil. The firm's strategy and business approach is based on five pillars that offer a sustainable development path for creating a successful company, which include Building a balanced portfolio. Evolva focuses on orally available small molecules in the belief that they are more convenient for patients and more cost-effective both from manufacture and administration points of view for the society, focus on differentiated pharmaceutical products with major benefits. Focusing on cardiovascular/renal and infectious diseases. Together they cause more than 50% of all deaths worldwide. Most of the top 20 pharmaceutical companies are active in both sectors, and all are active in one of the two sectors - hence widening Evolva's opportunities to partner. Building technology platform as the source of this differentiation. Evolva finds different structures with different properties from those found by the 99% of the industry that focuses on synthetic chemistry or proteins. Openness to unusual markets. The biotech business model has changed. As well as the established markets new opportunities arise in emerging countries such as India and China, and in adjacent sectors such as treatments against potential bio-terrorist and bio-warfare agents and the production of pharmaceutical and industrial chemical intermediates. Cost-effective implementation. Evolva places different functions around the globe according to where local conditions best suit. This approach both reduces Evolva's cost base and increases access to revenues, partners and talent. Evolva sees revenues and partners as important because they provide additional flexibility, resources and talent. Also, they provide important opportunities to better understand, and better meet, the needs of current and future customers.

Organon Pharmaceutical USA, Inc. markets and distributes pharmaceutical products. Its products include contraceptives and anesthetics, as well as treatments for mental health disorders. The company is headquartered in Roseland, NJ.

Ontwikkelingsmaatschappij Oost Nederland NV (Development Agency East Netherlands) is an Independent Private Equity/Venture Capital firm that focuses its activities on strengthening the economy of the provinces of Gelderland and Overijssel, the Netherlands. Oost NV is headquartered in Apeldoorn.

AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands.

InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands.

International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries.

DPG Media BV engages in the publication of national, regional, and local news papers, magazines and websites. Its brands include Algemeen Dagblad, AutoTrack, de Stentor, BrunoPress, de Volkskrant, Libelle, nu,nl, Independer, Startpagina, Trouw, Tweakers, Veronica Megazine, and Story. The company was founded in 1994 and is headquartered in Amsterdam, the Netherlands.

Part of Merck & Co., Inc., Merck Sharp & Dohme BV is a Dutch company that manufactures and distributes pharmaceutical products. The company is based in Haarlem, the Netherlands.

DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands.

iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark.

Panaxea BV provides science based solutions for biomedical companies. It operates as a management and consulting firm. The firm specializes in biomedical business development, business management support, and health economics. The company was founded by Maarten J. Ijzerman in 2010 and is headquartered in Amsterdam, the Netherlands.

Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California.

CatalYm GmbH specializes in catalyzing immunotherapy. The company is headquartered in Munich, Germany.

Part of Roche Holding AG, Roche Netherlands BV is a Dutch company that wholesales pharmaceuticals and diagnostics products. The company is based in Woerden, Netherlands.

Lygature is a not-for-profit organization that drives the development of new medical solutions for patients by managing public-private partnerships involving academia, industry, and society. The non-profit company is based in Utrecht, Netherlands, and provides specialized support for research consortia to address unmet medical needs worldwide. The Dutch company combines proprietary resources to find solutions for unmet medical needs by securing partners, acquiring funding, and sharing risks and resources. Lygature operates in the health innovation sector, where patients, doctors, healthcare providers, methodologists, CE-experts, entrepreneurs, insurers, investors, and regulatory authorities all contribute to delivering better medical devices faster. Lygature manages large multistakeholder partnerships in the life sciences and has 15 years of experience in starting and managing such partnerships.

Abata Therapeutics, Inc. is a biotech company based in Watertown, MA. Abata Therapeutics is focused on developing engineered Treg cell therapies for severe autoimmune and inflammatory diseases. The American company's lead programs are in ind-enabling studies for progressive multiple sclerosis and type 1 diabetes, both of which are tissue-specific autoimmune diseases with significant unmet needs. The company has developed a differentiated product engine to create tissue-specific, robust, and durable therapies. Abata Therapeutics was launched by Third Rock Ventures, with participation from a diverse syndicate of investors, including ElevateBio, Lightspeed Venture Partners, Invus, Samsara Biocapital, and the JDRF T1D Fund. The company was founded in 2021 by Richard Ransohoff and the CEO is Samantha Singer.

Sairopa B V is a Dutch company that develops medicines and operates as an investment holding company.

Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts.

Novamedia Holding BV operates charity lotteries. The private company is based in Amsterdam, the Netherlands, and has subsidiaries in the Netherlands, Sweden, the United Kingdom, and Germany.

Aduro Biotech Holdings Europe BV operates as a biopharmaceutical company specializing in immune oncology antibody discovery. The firm’s technology creates a pipeline of antibodies aiming to treat the immune system of cancer patients. Its antibody portfolio includes immune checkpoint inhibitors and novel antibody formats. The company was founded by Wiebe Olijve, Andrea van Elsas, and Hans van Eenennaam in 2011 and is headquartered in Oss, the Netherlands.